{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:46:12Z","timestamp":1791341172141,"version":"4.3.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.hfc.2009.04.010","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T11:09:12Z","timestamp":1248347352000},"page":"589-599","source":"Crossref","is-referenced-by-count":9,"title":["Biomarkers of Extracellular Matrix Turnover"],"prefix":"10.1016","volume":"5","author":[{"given":"Faiez","family":"Zannad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2009.04.010_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/16.suppl_C.38","article-title":"Collagen turnover and its regulation in the normal and hypertrophying heart","volume":"16","author":"Bishop","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2009.04.010_bib2","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/hy1101.099484","article-title":"Treatment of congestive heart failure: interfering the aldosterone\u2013cardiac extracellular matrix relationship","volume":"38","author":"Zannad","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2009.04.010_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1050-1738(01)00160-8","article-title":"Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction","volume":"12","author":"D'Armiento","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.hfc.2009.04.010_bib4","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2009.04.010_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.CIR.98.6.535","article-title":"Abnormalities of the extracellular degradation of collagen type I in essential hypertension","volume":"98","author":"Laviades","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib6","first-page":"2488","article-title":"Monitoring tissue repair and fibrosis from a distance","volume":"96","author":"Weber","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib7","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/01.hjh.0000173780.67308.f1","article-title":"The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease","volume":"23","author":"Lopez","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.hfc.2009.04.010_bib8","first-page":"77","article-title":"Analysing connective tissue metabolites in human serum. Biochemical, physiological, and methodological aspects","volume":"22","author":"Risteli","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.hfc.2009.04.010_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.81.1.52","article-title":"Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction","volume":"81","author":"Jensen","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib10","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/01.CIR.101.14.1729","article-title":"Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease","volume":"101","author":"Querejeta","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib11","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.CIR.0000140973.60992.9A","article-title":"Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis","volume":"110","author":"Querejeta","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib12","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","article-title":"Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients","volume":"105","author":"Diez","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib13","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib14","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1161\/CIRCULATIONAHA.105.571653","article-title":"Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study","volume":"112","author":"Izawa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2006.01.077","article-title":"Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure","volume":"48","author":"Lopez","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.04.010_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/eurheartj\/ehi007","article-title":"Ischaemia\u2013reperfusion injury activates matrix metalloproteinases in the human heart","volume":"26","author":"Lalu","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2009.04.010_bib17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1067\/mhj.2001.112238","article-title":"Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome","volume":"141","author":"Inokubo","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2009.04.010_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/01.RES.69.1.116","article-title":"Collagen expression in mechanically stimulated cardiac fibroblasts","volume":"69","author":"Carver","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2009.04.010_bib19","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/01.RES.67.6.1474","article-title":"Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats","volume":"67","author":"Mukherjee","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2009.04.010_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1253\/circj.71.716","article-title":"Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide","volume":"71","author":"Nakahara","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.hfc.2009.04.010_bib21","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.105.573865","article-title":"Matrix metalloproteinases\/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease","volume":"113","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib22","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/CIRCULATIONAHA.106.638569","article-title":"Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction","volume":"115","author":"Martos","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/01.HYP.0000024573.17293.23","article-title":"TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension","volume":"40","author":"Lindsay","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2009.04.010_bib24","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1097\/HJH.0b013e3282170ada","article-title":"Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)","volume":"25","author":"Muller-Brunotte","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.hfc.2009.04.010_bib25","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/hrt.2003.029702","article-title":"Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertension","volume":"91","author":"Poulsen","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2009.04.010_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijcard.2004.03.009","article-title":"Oxidative stress and fibrosis in incipient myocardial dysfunction in type 2 diabetic patients","volume":"101","author":"Gonzalez-Vilchez","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2009.04.010_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejheart.2005.06.008","article-title":"Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes","volume":"8","author":"Alla","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2009.04.010_bib28","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2337\/diacare.22.7.1186","article-title":"Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes","volume":"22","author":"Berg","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.hfc.2009.04.010_bib29","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.ijo.0803022","article-title":"Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance","volume":"29","author":"Quilliot","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.hfc.2009.04.010_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000096722","article-title":"Arterial stiffness and extracellular matrix","volume":"44","author":"Diez","year":"2007","journal-title":"Adv Cardiol"},{"key":"10.1016\/j.hfc.2009.04.010_bib31","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1291\/hypres.28.995","article-title":"Collagen metabolism in extracellular matrix may be involved in arterial stiffness in older hypertensive patients with left ventricular hypertrophy","volume":"28","author":"Ishikawa","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/j.hfc.2009.04.010_bib32","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1253\/circj.71.929","article-title":"Serum carboxy-terminal telopeptide of type I collagen (ICTP) predicts cardiac events in chronic heart failure patients with preserved left ventricular systolic function","volume":"71","author":"Kitahara","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.hfc.2009.04.010_bib33","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/01.CIR.0000085658.98621.49","article-title":"Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?","volume":"108","author":"Jugdutt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568006033337276","article-title":"Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways","volume":"3","author":"Jugdutt","year":"2003","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"10.1016\/j.hfc.2009.04.010_bib35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejheart.2006.09.010","article-title":"Residual stress ischaemia is associated with blood markers of myocardial structural remodeling","volume":"9","author":"Radauceanu","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2009.04.010_bib36","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1161\/01.CIR.96.8.2565","article-title":"Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency","volume":"96","author":"Uusimaa","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib37","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.101.13.1527","article-title":"Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction","volume":"101","author":"Poulsen","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib38","first-page":"152","article-title":"Clinical significance of matrix metalloproteinases activity in acute myocardial infarction","volume":"16","author":"Papadopoulos","year":"2005","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.hfc.2009.04.010_bib39","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1161\/CIRCULATIONAHA.108.809194","article-title":"Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the EPHESUS study","volume":"119","author":"Iraqi","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.hfc.2009.04.010_bib40","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/clinchem\/44.12.2453","volume":"44","author":"Murakami","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.hfc.2009.04.010_bib41","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.amjcard.2006.09.114","article-title":"Relation between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction","volume":"99","author":"Cerisano","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2009.04.010_bib42","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/CIRCULATIONAHA.105.600353","article-title":"Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling","volume":"114","author":"Webb","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib43","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI115414","article-title":"Alteration of collagen phenotypes in ischemic cardiomyopathy","volume":"88","author":"Mukherjee","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hfc.2009.04.010_bib44","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9149(99)80686-9","article-title":"Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis","volume":"75","author":"Klappacher","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2009.04.010_bib45","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES). RALES Investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardfail.2008.02.014","article-title":"Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure","volume":"14","author":"Radauceanu","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.hfc.2009.04.010_bib47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1253\/circj.71.631","article-title":"Cardiac troponin T vs other biochemical markers in patients with congestive heart failure","volume":"71","author":"Nishio","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.hfc.2009.04.010_bib48","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/hrt.2006.101261","article-title":"Left atrial volume provides independent and incremental information compared with exercise tolerance parameters in patients with heart failure and left ventricular systolic dysfunction","volume":"93","author":"Rossi","year":"2007","journal-title":"Heart"},{"issue":"93","key":"10.1016\/j.hfc.2009.04.010_bib49","first-page":"e1","article-title":"Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy","volume":"152","author":"Bonapace","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2009.04.010_bib50","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.hrthm.2006.12.040","article-title":"Atrial fibrosis and the mechanisms of atrial fibrillation","volume":"4","author":"Everett","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hfc.2009.04.010_bib51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1582-4934.2008.00219.x","article-title":"Atrial extracellular matrix remodeling in patients with atrial fibrillation","volume":"12","author":"Polyakova","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.hfc.2009.04.010_bib52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jacc.2008.03.045","article-title":"Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover","volume":"52","author":"Kallergis","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2009.04.010_bib53","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1253\/circj.72.1120","article-title":"Circulating adiponectin levels in patients with atrial fibrillation","volume":"72","author":"Shimano","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.hfc.2009.04.010_bib54","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/europace\/eum072","article-title":"Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation","volume":"9","author":"Tziakas","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.hfc.2009.04.010_bib55","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1517\/14656566.8.14.2225","article-title":"Effect of angiotensin-converting enzyme insertion\/deletion genotype on collagen type I synthesis and degradation in patients with atrial fibrillation and arterial hypertension","volume":"8","author":"Tziakas","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.hfc.2009.04.010_bib56","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/europace\/eum102","article-title":"Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction","volume":"9","author":"Blangy","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.hfc.2009.04.010_bib57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.CIR.0000137118.47943.5C","article-title":"Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trial","volume":"110","author":"Ciulla","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib58","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1210\/en.2006-0826","article-title":"Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects","volume":"147","author":"Funder","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.hfc.2009.04.010_bib59","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MNH.0b013e3282f56854","article-title":"Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation","volume":"17","author":"Young","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.hfc.2009.04.010_bib60","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2009.04.010_bib61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1291\/hypres.24.99","article-title":"High serum level of procollagen type III amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients","volume":"24","author":"Sato","year":"2001","journal-title":"Hypertens Res"},{"key":"10.1016\/j.hfc.2009.04.010_bib62","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10741-005-2351-3","article-title":"Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure","volume":"10","author":"Zannad","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hfc.2009.04.010_bib63","first-page":"145","article-title":"Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia","volume":"54","author":"Majima","year":"2007","journal-title":"Endocrinol Jpn"},{"key":"10.1016\/j.hfc.2009.04.010_bib64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.amjcard.2007.02.085","article-title":"Effects of valsartan alone versus valsartan\/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension","volume":"100","author":"Rajagopalan","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2009.04.010_bib65","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1749-6632.1999.tb07687.x","article-title":"Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications","volume":"878","author":"Zucker","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.hfc.2009.04.010_bib66","first-page":"683","volume":"58","author":"Garnero","year":"2000","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.hfc.2009.04.010_bib67","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0002-9440(10)64447-1","article-title":"Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms","volume":"161","author":"Fontaine","year":"2002","journal-title":"Am J\u00a0Pathol"},{"key":"10.1016\/j.hfc.2009.04.010_bib68","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/clinchem\/42.12.2043","article-title":"Role of specimen collection in preanalytical variation of metalloproteinases and their inhibitors in blood","volume":"42","author":"Jung","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.hfc.2009.04.010_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0065-2423(04)38002-9","article-title":"Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications","volume":"38","author":"Zucker","year":"2004","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.hfc.2009.04.010_bib70","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.2165\/00003495-200666160-00001","article-title":"Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls","volume":"66","author":"Cremers","year":"2006","journal-title":"Drugs"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713609000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713609000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T22:45:44Z","timestamp":1590014744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713609000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1551713609000373"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2009.04.010","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}